ArticlePharmacological reports : PR2022
Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer.
Yasmin M Attia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticlePharmacological reports : PR2022
Yasmin M Attia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.